3D Bioprinting Market Worth $2.4 billion | MarketsandMarkets™

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170201787 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170201787 Browse in-depth TOC on "3D Bioprinting Market" 530 - Tables46 - Figures453 - Pages 3D Bioprinting Market Scope: The 3D Bioprinters segment segment is expected to have the dominant share of the 3D bioprinting market in 2023. Based on component, the global 3D...
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170201787

Browse in-depth TOC on "3D Bioprinting Market"

530 - Tables
46 - Figures
453 - Pages

3D Bioprinting Market Scope:

The 3D Bioprinters segment segment is expected to have the dominant share of the 3D bioprinting market in 2023.

Based on component, the global 3D bioprinting market is segmented into 3D bioprinters, bioinks, software and consumables. 3D bioprinters accounted for the larger market share in 2023. The segment is witnessing growth driven by technological innovations and escalating demand for organ transplantation services.

The Research applications segment is expected to account for the largest share of the application segment in the 3D bioprinting market in 2023.

Based on application, the 3D bioprinting market is segmented into research applications and clinical applications. research applications segment accounted for the larger share of the 3D bioprinting market in 2023. The market for research applications is further segmented into drug research, regenerative medicine, and 3D cell culture. Among these, the drug research segment accounted for the largest share of the market during forecast period of 2024-2029, due to the pharmaceutical & biotechnology firms intensifying their integration of 3D bioprinting technology.

The Asia Pacific region is anticipated to grow at significant CAGR during the forecast period.

The Asia Pacific is accounted to be the fastest-growing segment of the market. Large population base and robust domestic manufacturing capabilities for systems, fostering heightened partnerships and collaborations geared towards healthcare enhancement characterized by substantial investment in research and development (R&D), rising demand for organ transplants, rising government funding for advancement of 3D bioprinting technology in the region. Additionally, notable surge in stem cell research activities across several APAC countries, further contributing to the biomedical landscape is driving 3D bioprinting uptake in the region.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170201787

3D Bioprinting Market Dynamics:

Drivers:

1.  Growing adoption of 3D bioprinting technology within the pharmaceutical and cosmetic industries

Restraints:

1.  High cost of 3D bioprinters and bioinks

Opportunities:

1.  Rising demand for organ transplants

Challenge:

1.  Biocompatibility issues and rigorous sterilization protocols

Key Market Players of 3D Bioprinting Industry:

BICO Group AB (US), 3D Systems, Inc. (US), Merck KGaA (Germany), Organovo Holings Inc (US), CollPlant Biotechnologies Ltd. (Israel), regenHU (Switzerland), Aspect Biosystem Ltd. (Canada), Advanced Solutions Life Sciences, LLC (US), Cyfuse Biomedical K.K (Japan), Rokit Healthcare Inc. (South Korea), Hangzhou Genofei Biotechnology Co., Ltd. (China), Foldink (Armenia), Brinter (US) and 3D bioprinting solution (Russia) and REGEMAT 3D, SL (Spain) are some of the leading players in this market. Most companies in the market focus on organic and inorganic growth strategies, such as product launches, expansions, acquisitions, partnerships, agreements, and collaborations, to increase their product offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

The primary interviews conducted for this report can be categorized as follows:

3D Bioprinting Market Worth $2.4 billion | MarketsandMarkets™

Recent Developments of 3D Bioprinting Industry:

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=170201787

3D Bioprinting Market - Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall 3D bioprinting market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Related Reports:

Biomaterials Market - Global Forecasts to 2029

In Vitro Diagnostics Market - Global Forecasts to 2029

3D Cell Culture Market - Global Forecasts to 2028

3D Printing Medical Devices Market - Global Forecasts to 2028

4D Printing in Healthcare Market - Global Forecasts to 2026

Get access to the latest updates on 3D Bioprinting Companies and 3D Bioprinting Market Share

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/3d-bioprinting-market-worth-2-4-billion--marketsandmarkets-302148749.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;